Japanese Food Stock News

China’s latest export controls on Japanese defense and technology companies have pushed supply chain security and rare earth independence back into the spotlight. For investors, this kind of shock can quickly reshape how risk and opportunity are priced across Japanese stocks exposed to the news. This article breaks down what the policy shift might mean for larger domestic supply chain players, and why some of them could see changing expectations around their role in Japan’s push for...

DCM Holdings earnings event and what it means for investors DCM Holdings (TSE:3050) has drawn fresh attention after reporting first quarter results to May 31, 2026, with sales of ¥151,942 million and net income of ¥6,558 million, both higher than a year earlier. See our latest analysis for DCM Holdings. Despite the stronger first quarter figures, DCM Holdings’ recent share price performance has been mixed. The 1-day share price return was 1.01%, but the 90-day share price return declined...

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Sompo Holdings (TSE:8630) is back in focus after the company reported progress on its open market share repurchase program, including completion of a ¥9.75b tranche. This has sharpened attention on its capital allocation plans. See our latest analysis for Sompo Holdings. The share buyback update comes after a strong run in Sompo Holdings' stock, with a 1 month share price return of 14.78% and a year to date share price return of 24.63%, alongside a 1 year total shareholder return of 65.55%...

While TOKYO KEIKI INC. ( TSE:7721 ) might not have the largest market cap around , it received a lot of attention from...

Nippon Shinyaku Co., Ltd. recently entered into an option agreement with Elixirgen Therapeutics to potentially secure exclusive worldwide rights to develop and commercialize EXG-7001, an investigational mRNA-based therapy for Duchenne muscular dystrophy that is currently in preclinical development ahead of planned U.S. trials. This move deepens Nippon Shinyaku’s rare-disease focus by targeting full-length dystrophin expression regardless of mutation type, potentially broadening the...

Daiichi Sankyo and AstraZeneca recently secured a European Commission approval for Enhertu across multiple HER2 positive metastatic solid tumors and received an EMA committee recommendation for Datroway as first-line treatment for certain triple-negative breast cancer patients, alongside board decisions on share-based compensation. These oncology milestones expand Daiichi Sankyo’s European treatment footprint, trigger a US$25 million milestone payment from AstraZeneca, and reinforce the...

In recent days, Morgan Stanley MUFG highlighted Yaskawa Electric’s outlook by pointing to expectations for strong first-quarter earnings and accelerating order growth. This focus on both earnings strength and order momentum underscores how closely investors are watching demand trends in factory automation and robotics. With these expectations around first-quarter earnings and order momentum in mind, we will now examine how this shapes Yaskawa Electric’s investment narrative. The best AI...

Sumitomo Mitsui Financial Group recently completed a share repurchase of 17,614,900 shares, or 0.46% of its stock, for ¥108,513.1 million, alongside multiple US dollar fixed-to-floating and floating rate bond issues totaling US$2.75 billion and governance updates including a stock split and dividend approval. Together with fresh Managing Director appointments across key regions and the election of a new director, these actions underscore SMFG’s focus on capital return, funding flexibility,...

Oracle Corporation Japan (TSE:4716) updated investors with new guidance for the year ending May 31, 2027, alongside an increase in its regular dividend and a sizeable special dividend that highlight current shareholder returns. See our latest analysis for Oracle Corporation Japan. At a share price of ¥8,826, Oracle Corporation Japan has recently gained ground with a 1-day share price return of 0.91% and a 7-day share price return of 3.65%. However, the share price return is still down 30.37%...

Mitsui (TSE:8031) is drawing investor attention after increasing its India exposure, targeting semiconductors, e-mobility, and circular economy projects as Japanese investment into the country has reached about $25-35 billion post-COVID. See our latest analysis for Mitsui. At a share price of ¥4,600.0, Mitsui’s short term share price return has weakened, with a 30 day share price return down 8.71% and a 90 day share price return down 27.72%, even as the 1 year total shareholder return of...

Terumo Interventional Systems recently completed the first U.S. procedure using its OPUSWAVE Dual Sensor Imaging System at Mount Sinai Fuster Heart Hospital, combining Optical Frequency Domain Imaging and intravascular ultrasound in a single catheter to enhance intravascular imaging for coronary interventions. This dual-modality platform directly targets physicians’ demand for clearer, real-time vessel visualization and procedural confidence, potentially strengthening Terumo’s position in...

ASKUL (TSE:2678) has just posted its FY 2026 numbers, with fourth quarter revenue of ¥113.3b and a basic EPS loss of ¥90.78, capping a trailing twelve month picture that shows revenue of ¥400.2b and a full year EPS loss of ¥245.40. Over recent periods, the company has seen quarterly revenue move from ¥122.3b in Q4 FY 2025 to ¥113.3b in Q4 FY 2026, while quarterly basic EPS shifted from ¥31.42 to a loss of ¥90.78, underscoring a clear hit to profitability. For investors, these results put...

Investors in Kusuri No Aoki Holdings Co., Ltd. ( TSE:3549 ) had a good week, as its shares rose 5.8% to close at...

Hiday Hidaka (TSE:7611) opened fiscal 2027 with Q1 revenue of ¥16.99b and basic EPS of ¥39.89, setting the tone for a quarter where earnings and top line both sit clearly on the radar for investors watching how the story evolves from here. The company has seen quarterly revenue move from ¥14.67b in Q4 2025 to ¥16.99b in Q1 2027, while basic EPS has shifted from ¥35.46 to ¥39.89 over the same period. These trends now feed into a setup where slightly higher net profit margins put more focus on...

West Japan Railway (TSE:9021) is back in focus after its latest quarterly results delivered an earnings per share surprise of 14.90 ¥ versus an estimated 5.05 ¥, alongside a 3.57% single day stock move. See our latest analysis for West Japan Railway. That earnings surprise has come alongside an 11.48% 1 month share price return, although the 1 year total shareholder return is still down 10.93% and the 5 year total shareholder return is slightly negative, so momentum appears more short term...

Nagase’s Detroit expansion puts automotive focus in the spotlight Nagase (TSE:8012) stock is drawing fresh attention after Nagase America officially opened its Mobility Solutions office in downtown Detroit, positioning the group closer to key global automotive customers. See our latest analysis for Nagase. Nagase’s recent Detroit move comes on the back of a strong run, with the share price at ¥1,200 and a year to date share price return of 22.8% alongside a 1 year total shareholder return of...

Stone fruit exports rising 15% year on year to more than 32 million cartons, even with higher tariffs and fewer ships, point to a powerful mix of demand strength and supply chain resilience. For investors, that kind of real economy shift can matter just as much as any earnings release, especially for stocks tied directly to seed supply, premium produce exports, and food retail. This article breaks down 3 stocks exposed to that export upswing and explains how each is positioned in the current...

Amiyaki Tei (TSE:2753) has opened Q1 2027 earnings season with investors focused on how its recent revenue and EPS trends set up the rest of the year, after trailing 12 month net margin of 3.4% has been flagged alongside an unstable dividend record. The company has seen quarterly revenue move from ¥8,553 million in Q3 2025 to ¥10,099 million in Q4 2026, with basic EPS shifting over the same stretch from ¥17.96 to ¥21.56, and forecasts pointing to around 6.5% annual revenue growth and about...

World (TSE:3612) kicked off Q1 2027 with revenue of ¥76.1 billion and net income of ¥2,268 million, translating to basic EPS of ¥31.18, against a backdrop of trailing 12 month EPS of ¥171.36 on revenue of ¥284.0 billion. The company has seen quarterly revenue move from ¥58.6 billion in Q4 2025 to ¥70.0 billion in Q1 2026 and then to ¥76.1 billion in Q4 2026, while EPS over the same quarters shifted from ¥36.57 to ¥63.38 and then to ¥31.18. This leaves investors focused on how a 4.2% trailing...

Sompo Holdings recently completed a tranche of its board-approved share buyback program, repurchasing 1,596,800 shares, or 0.18% of outstanding stock, for ¥9,746.98 million between May 20 and June 30, 2026. The board’s focus on monitoring and approving progress of these buybacks underscores management’s commitment to using excess capital to improve capital efficiency and shareholder returns. We’ll now examine how Sompo Holdings’ ongoing share repurchases, and the associated reduction in...

MTG Co., Ltd. recently reported past quarterly revenue of ¥32.11 billion that surpassed analyst expectations, signaling stronger-than-anticipated business performance and execution of its current plan. The earnings surprise is also drawing attention to MTG’s AI-driven initiatives, such as ReFa Color Recipe PRO, which have become central to its growth ambitions and dividend story. Next, we’ll examine how this revenue beat and growing focus on AI-powered products shape MTG’s broader investment...

Metaplanet’s latest Bitcoin move and what it means for the stock Metaplanet (TSE:3350) has drawn fresh attention after purchasing an additional 2,823 Bitcoin, taking its total holdings to 43,000 BTC and positioning the company as the world’s third largest publicly traded Bitcoin holder. See our latest analysis for Metaplanet. Metaplanet’s aggressive Bitcoin accumulation has arrived during a volatile period for the stock, with the 1-day share price return of 3.38% and 7-day return of 8.63%...

Kamigumi (TSE:9364) has announced a share repurchase program of up to 4,200,000 shares, or 4.25% of its issued share capital, totaling ¥15,000 million, following board approval on June 26, 2026. See our latest analysis for Kamigumi. The buyback decision comes after a mixed year for Kamigumi’s stock, with a 7 day share price return of 9.42% and a 30 day share price return of 10.23%. However, the 90 day share price return declined 5.03%, while the 1 year total shareholder return of 34.67% and 3...